Skip to main content
INNOGENE Co., Ltd. logo

INNOGENE Co., Ltd. — Investor Relations & Filings

Ticker · 344860 ISIN · KR7344860002 KO Manufacturing
Open in API
Filings indexed 144 across all filing types
Latest filing 2025-10-17 Regulatory Filings
Country KR South Korea
Listing KO 344860

About INNOGENE Co., Ltd.

http://eng.innogene.com

INNOGENE Co., Ltd. is a company specializing in anti-aging solutions. It develops, manufactures, and distributes advanced therapeutic products and cosmetics focused on skin regeneration and hair follicle health. The company's research and development leverages core technologies in medical informatics and a stem cell database to create its product portfolio. These solutions are designed to address concerns related to skin aging and hair loss, based on scientific studies of stem cell applications and healthy beauty.

Recent filings

Filing Released Lang Actions
주주총회소집결의 (임시주주총회)
Regulatory Filings Classification · 95% confidence The document is a notice of convening a shareholders' meeting (임시주주총회, or extraordinary general meeting) with details on date, time, location, agenda items, and board resolution date. It is not a report or financial statement but an announcement related to the meeting itself. The content fits the category of announcements about shareholder meetings rather than the meeting materials or voting results. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the meeting convocation and does not fit more specific categories like AGM Information or Declaration of Voting Results.
2025-10-17 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document text is a brief announcement regarding the setting of a record date and closure period for the shareholder register, specifically for determining shareholders eligible to exercise voting rights at a special shareholders' meeting. It includes dates for the record date and board resolution but does not contain financial data or detailed report content. The document is short (440 characters) and serves as a notification of shareholder register closure, which is typically a regulatory announcement related to shareholder rights and meeting preparations. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not match other more specific categories like AGM materials or dividend notices.
2025-10-17 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '주식회사 이노진' (Innogene Co., Ltd.) covering the period from January 1, 2025, to June 30, 2025. It contains detailed business information, financial data, and management disclosures typical of an interim report. According to the provided definitions, a comprehensive financial report for a period shorter than a full fiscal year (like a half-year report) is classified as an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
자기주식취득결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '자기주식취득결과보고서' (Report on the Results of Treasury Stock Acquisition) filed with the Financial Supervisory Service (FSS) in South Korea. It details the specific dates, quantities, and prices of shares repurchased by the company (Innogene) over a defined period. This falls directly under the category of a company reporting its own share buyback activities.
2025-07-30 Korean
주요사항보고서(자기주식취득결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange. The specific content details a 'Decision to Acquire Treasury Shares' (자기주식 취득 결정), which is a formal announcement of a share buyback program. According to the provided definitions, reports regarding a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2025-06-09 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '(주)이노진' (Innogene) for the first quarter of 2025 (2025.01.01 - 2025.03.31). It contains detailed financial and operational data, including business overview, product sales, production capacity, and revenue breakdowns. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.